IFP Advisors’s Matinas BioPharma MTNB Stock Holding History

IFP Advisors’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$1	–	4527
2024 Q4	$1	Buy	+2	New	+$3	﹤0.01%	4588
2024 Q3	–	Sell	-13	Closed	-$102	–	3397
2024 Q2	$102	Hold	13	–	–	﹤0.01%	3168
2024 Q1	$174	Hold	13	–	–	﹤0.01%	3037
2023 Q4	$139	Hold	13	–	–	﹤0.01%	2957
2023 Q3	$83	Hold	13	–	–	﹤0.01%	3227
2023 Q2	$231	Hold	13	–	–	﹤0.01%	3304
2023 Q1	$383	Hold	13	–	–	﹤0.01%	3216
2022 Q4	$2K	Hold	13	–	–	﹤0.01%	4187
2022 Q3	$2K	Hold	13	–	–	﹤0.01%	4381
2022 Q2	$2K	Hold	13	–	–	﹤0.01%	4153
2022 Q1	$2K	Hold	13	–	–	﹤0.01%	4151
2021 Q4	$2K	Hold	13	–	–	﹤0.01%	2817
2021 Q3	$2K	Hold	13	–	–	﹤0.01%	2880
2021 Q2	$0	Sell	13 -254	-95%	-$10.9K	﹤0.01%	3159
2021 Q1	$14K	Buy	267 +67	+34%	+$4.49K	﹤0.01%	2001
2020 Q4	$14K	Buy	+200	New	+$9.26K	﹤0.01%	1932
2019 Q1	–	Sell	-35,500	Closed	-$1.08M	–	3020
2018 Q4	$1.08M	Buy	35,500 +24,477	+222%	+$960K	0.07%	333
2018 Q3	$507K	Hold	11,023	–	–	0.02%	653
2018 Q2	$239K	Buy	11,023 +6,000	+119%	+$173K	0.01%	975
2018 Q1	$291K	Hold	5,023	–	–	0.01%	835
2017 Q4	$291K	Sell	5,023 -8,977	-64%	-$577K	0.01%	836
2017 Q3	$924K	Hold	14,000	–	–	0.04%	464
2017 Q2	$1.18M	Buy	+14,000	New	+$1.88M	0.05%	384

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

HIW

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IFP Advisors's MTNB Position: Q1 2025 in Review

IFP Advisors sold out of Matinas BioPharma (MTNB) in Q1 2025, closing a stake of 2 shares — an estimated $1 sold.

IFP Advisors first reported a position in MTNB in Q2 2017 and held it in 23 quarters. The position peaked at $1.18M in Q2 2017. 25 funds tracked by Wall St. Rank hold MTNB as of Q1 2025.

IFP Advisors reported no remaining Matinas BioPharma position as of Q1 2025 after selling out during the quarter.
IFP Advisors sold 2 Matinas BioPharma shares in Q1 2025, an estimated $1.
IFP Advisors first reported a position in Matinas BioPharma in Q2 2017 and held it in 23 quarters.
IFP Advisors's Matinas BioPharma position peaked at $1.18M in Q2 2017.
25 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.